← 產業報告目錄
Veterinary Distribution Market Size, Share & Trends Analysis Distribution by Product (Pharmaceuticals, Biologics, Medicinal Feed Additives), Animal Type (Companion Animals (Dogs, Cats, Horses, Others), Production Animals (Cattle, Swine, Poultry, Sheep & Goats, Fish)), Distribution Channel (Hospital/ Clinic Pharmacy, Retail, E-commerce), Sales Type (Prescription, OTC) and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-09頁數 179報告編號 INSIGHTACE-e0810d4036
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Across the 2024 to 2034 projection horizon, the worldwide Veterinary Distribution Market is forecasted to register a CAGR of 7.4%.
At its core, Veterinary Distribution pertains to The veterinary distribution industry plays a central role in guaranteeing the availability and accessibility of critical veterinary products, such as pharmaceuticals, vaccines, and diagnostics, to dif. Stakeholders across the healthcare landscape are expandingly turning to these solutions to meet contemporary demands.
Market momentum is fueled by expanding requirement advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Veterinary Pharma Distribution Market Snapshot
Chapter 4. Global Veterinary Pharma Distribution Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Global Veterinary Pharma Distribution Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Veterinary Pharma Distribution Market Industry Trends
Chapter 5. Veterinary Pharma Distribution Market Segmentation 1: By Products, Estimates & Trend Analysis
5.1. Market Share by Products, 2023 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Products:
5.2.1. Pharmaceuticals
5.2.1.1. Parasiticides
5.2.1.2. Anti-infectives
5.2.1.3. Anti-inflammatory
5.2.1.4. Analgesic
5.2.1.5. Others
5.2.2. Biologics
5.2.2.1. Vaccines
5.2.2.1.1. Modified/ Attenuated Live
5.2.2.1.2. Inactivated (Killed)
5.2.2.1.3. Others
5.2.2.2. Other Biologics
5.2.3. Medicinal Feed Additives
Chapter 6. Veterinary Pharma Distribution Market Segmentation 2: By Animal Type, Estimates & Trend Analysis
6.1. Market Share by Animal Type, 2023 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Animal Type:
6.2.1. Companion Animals
6.2.1.1. Dogs
6.2.1.2. Cats
6.2.1.3. Horses
6.2.1.4. Others
6.2.2. Production Animals
6.2.2.1. Cattle
6.2.2.2. Swine
6.2.2.3. Poultry
6.2.2.4. Sheep & Goats
6.2.2.5. Fish
Chapter 7. Veterinary Pharma Distribution Market Segmentation 3: By Sales Type, Estimates & Trend Analysis
7.1. Market Share by Sales Type, 2023 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Sales Type:
7.2.1. Pharmaceuticals
7.2.1.1. Prescription
7.2.1.2. OTC
7.2.2. Biologics
7.2.2.1. Prescription
7.2.2.2. OTC
7.2.3. Medicinal Feed Additives
7.2.3.1. Prescription
7.2.3.2. OTC
Chapter 8. Veterinary Pharma Distribution Market Segmentation 4: By Distribution Channel, Estimates & Trend Analysis
8.1. Market Share by Distribution Channel, 2023 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
8.2.1. Pharmaceuticals
8.2.1.1. Hospital/ Clinic Pharmacy
8.2.1.2. Retail
8.2.1.3. E-commerce
8.2.2. Biologics
8.2.2.1. Hospital/ Clinic Pharmacy
8.2.2.2. Retail
8.2.2.3. E-commerce
8.2.3. Medicinal Feed Additives
8.2.3.1. Hospital/ Clinic Pharmacy
8.2.3.2. Retail
8.2.3.3. E-commerce
Chapter 9. Veterinary Pharma Distribution Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Veterinary Pharma Distribution Market, Regional Snapshot 2023 & 2034
9.2. North America
9.2.1. North America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.2.3. North America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.2.4. North America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Sales Type, 2021-2034
9.2.5. North America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.3. Europe
9.3.1. Europe Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.3.3. Europe Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.3.4. Europe Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Sales Type, 2021-2034
9.3.5. Europe Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.4.3. Asia Pacific Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.4.4. Asia Pacific Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts By Sales Type, 2021-2034
9.4.5. Asia Pacific Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.5. Latin America
9.5.1. Latin America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.5.3. Latin America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.5.4. Latin America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Sales Type, 2021-2034
9.5.5. Latin America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.6.3. Middle East & Africa Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.6.4. Middle East & Africa Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Sales Type, 2021-2034
9.6.5. Middle East & Africa Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles (Major Manufacturer)
10.2.1. Elanco
10.2.2. Merck & Co Inc.
10.2.3. Boehringer Ingelheim Animal Health
10.2.4. Alembic Pharmaceuticals Limited
10.2.5. HIPRA, S.A.
10.2.6. Norbrook
10.2.7. Dechra Pharmaceuticals plc
10.2.8. Mars, Inc.
10.2.9. Animalcare Group plc
10.2.10. Vetoquinol S.A.
10.2.11. Zoetis Services LLC
10.2.12. Ceva
10.2.13. Virbac
10.3. Company Profiles (Major Distributors)
10.3.1. Midwest Veterinary Supply
10.3.2. Petsmart LLC
10.3.3. Covetrus, Inc
10.3.4. Pet Supermarket, Inc.
10.3.5. Petsense
10.3.6. Petco Animal Supplies, Inc
10.3.7. Chewy, Inc.
10.3.8. Tractor Supply Co.
10.3.9. Shop-Apotheke
10.3.10. PetFriendly
10.3.11. Amazon, Inc.
10.3.12. Walmart
10.3.13. Gianteagle pet pharmacy
10.3.14. Netmeds
10.3.15. PetRx
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們